Model of proportional hazards. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms1

Diseases61

Cardiovascular Diseases Breast Neoplasms Disease Progression Neoplasm Recurrence, Local Recurrence Stroke Kidney Failure, Chronic Prostatic Neoplasms Myocardial Infarction Lung Neoplasms Coronary Disease Heart Failure Colorectal Neoplasms Neoplasms HIV Infections Lymphatic Metastasis Adenocarcinoma Diabetes Mellitus, Type 2 Diabetes Mellitus Hypertension Liver Neoplasms Diabetes Complications Coronary Artery Disease Ovarian Neoplasms Dementia Carcinoma, Squamous Cell Hip Fractures Death, Sudden, Cardiac Neoplasm Invasiveness Chronic Disease Occupational Diseases Obesity Kidney Neoplasms Carcinoma, Non-Small-Cell Lung Death Stomach Neoplasms Carcinoma, Hepatocellular Endometrial Neoplasms Brain Neoplasms Esophageal Neoplasms Kidney Diseases Pancreatic Neoplasms Neoplasm Metastasis Postoperative Complications Carcinoma, Renal Cell Atrial Fibrillation Genetic Predisposition to Disease Carcinoma Colonic Neoplasms Neoplasms, Glandular and Epithelial Melanoma Cerebrovascular Disorders Neoplasms, Second Primary Renal Insufficiency Urinary Bladder Neoplasms Skin Neoplasms Peripheral Arterial Disease Fractures, Bone Adenocarcinoma, Mucinous Myocardial Ischemia Heart Diseases

Chemicals and Drugs17

Tumor Markers, Biological Biological Markers Prostate-Specific Antigen Coffee Receptors, Estrogen Anti-HIV Agents Creatinine Hazardous Substances Receptors, Progesterone C-Reactive Protein Hydroxymethylglutaryl-CoA Reductase Inhibitors beta Carotene Antineoplastic Agents, Hormonal Aspirin Androgen Antagonists Antineoplastic Agents Natriuretic Peptide, Brain

Analytical, Diagnostic and Therapeutic Techniques and Equipment88

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Prognosis Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Risk Assessment Treatment Outcome Predictive Value of Tests Risk Cause of Death Neoplasm Staging Disease-Free Survival Longitudinal Studies Confidence Intervals Mortality Registries SEER Program Questionnaires Body Mass Index Regression Analysis Chi-Square Distribution Odds Ratio Renal Dialysis Severity of Illness Index Epidemiologic Methods Hospitalization Models, Statistical Probability Chemotherapy, Adjuvant Case-Control Studies Propensity Score Treatment Failure Combined Modality Therapy Analysis of Variance Logistic Models Randomized Controlled Trials as Topic Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Prostatectomy Life Tables Prevalence Nomograms Neoplasm Grading Immunohistochemistry Reproducibility of Results Biometry Biostatistics Antineoplastic Combined Chemotherapy Protocols Double-Blind Method ROC Curve Glomerular Filtration Rate Population Surveillance Diet Surveys Obesity Blood Pressure Data Interpretation, Statistical Health Surveys Estrogen Replacement Therapy Multicenter Studies as Topic Radiotherapy, Adjuvant Kidney Transplantation Karnofsky Performance Status Peritoneal Dialysis Reproductive History Linear Models Actuarial Analysis Patient Selection Viral Load Stroke Volume Morbidity Reoperation Electrocardiography Statistics, Nonparametric Likelihood Functions Drug Administration Schedule Sensitivity and Specificity Mortality, Premature Patient Readmission Statistics as Topic Endpoint Determination Models, Biological

Psychiatry and Psychology5

Smoking Alcohol Drinking Life Style Food Habits Dementia

Phenomena and Processes28

Time Factors Risk Body Mass Index Chi-Square Distribution Odds Ratio Postmenopause Diet Probability CD4 Lymphocyte Count Genotype Nomograms Glomerular Filtration Rate Obesity Blood Pressure Polymorphism, Single Nucleotide Pregnancy Aging Graft Survival Genetic Predisposition to Disease Menopause Viral Load Algorithms Stroke Volume Dose-Response Relationship, Drug Sensitivity and Specificity Vascular Patency Polymorphism, Genetic Time-to-Pregnancy

Disciplines and Occupations3

Immunohistochemistry Outcome Assessment (Health Care)Statistics as Topic

Anthropology, Education, Sociology and Social Phenomena8

Age Distribution Sex Distribution Socioeconomic Factors Survival Forecasting National Institutes of Health (U.S.)Social Class Health Status

Technology, Industry, Agriculture6

Coffee Vegetables Fruit Dairy Products Meat Dietary Supplements

Information Science15

Incidence Survival Rate Cause of Death Mortality Registries SEER Program Questionnaires Databases, Factual Life Tables Prevalence Data Interpretation, Statistical Algorithms Computer Simulation Morbidity Mortality, Premature

Named Groups11

European Continental Ancestry Group African Americans African Continental Ancestry Group Veterans Infant, Newborn Ethnic Groups Asian Continental Ancestry Group Survivors Continental Population Groups Hispanic Americans Nurses

Health Care84

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Risk Assessment Treatment Outcome Predictive Value of Tests Risk Cause of Death Age Factors Disease-Free Survival Longitudinal Studies Confidence Intervals Mortality Registries Sex Factors SEER Program Questionnaires Body Mass Index Comorbidity Confounding Factors (Epidemiology)Regression Analysis Chi-Square Distribution Odds Ratio Severity of Illness Index Epidemiologic Methods Hospitalization Age Distribution Models, Statistical Probability Case-Control Studies Propensity Score Treatment Failure Sex Distribution Analysis of Variance Logistic Models Randomized Controlled Trials as Topic Socioeconomic Factors Life Tables Prevalence Nomograms Women's Health Age of Onset Occupational Exposure Reproducibility of Results Biometry Double-Blind Method Residence Characteristics ROC Curve Population Surveillance Diet Surveys Data Interpretation, Statistical Health Surveys Ethnic Groups Multicenter Studies as Topic Outcome Assessment (Health Care)Medicare Karnofsky Performance Status Educational Status Bias (Epidemiology)Reproductive History Linear Models Actuarial Analysis Patient Selection Morbidity National Institutes of Health (U.S.)Pensions Statistics, Nonparametric Likelihood Functions Nurses Environmental Exposure Sensitivity and Specificity Mortality, Premature Patient Readmission Social Class Health Status Statistics as Topic

Geographicals28

United States Japan Taiwan Sweden California Denmark China Netherlands Finland British Columbia Minnesota Norway Europe Iowa Germany Maryland Italy France Western Australia Hawaii Canada Australia Massachusetts Washington Korea Austria Texas Great Britain

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Prognosis Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Time Factors Risk Assessment Treatment Outcome Predictive Value of Tests United States Risk Cause of Death Age Factors Neoplasm Staging Disease-Free Survival Longitudinal Studies Confidence Intervals Mortality Registries Cardiovascular Diseases Breast Neoplasms Disease Progression Smoking Sex Factors Japan SEER Program Questionnaires Neoplasm Recurrence, Local Recurrence Stroke Kidney Failure, Chronic Tumor Markers, Biological Body Mass Index Comorbidity Confounding Factors (Epidemiology)Prostatic Neoplasms European Continental Ancestry Group Regression Analysis Chi-Square Distribution Myocardial Infarction Odds Ratio Renal Dialysis Taiwan Severity of Illness Index Biological Markers Epidemiologic Methods Lung Neoplasms Coronary Disease Sweden Heart Failure Colorectal Neoplasms Postmenopause Diet Neoplasms HIV Infections California Lymphatic Metastasis Hospitalization African Americans Adenocarcinoma Age Distribution Models, Statistical Diabetes Mellitus, Type 2 Diabetes Mellitus Probability Alcohol Drinking Chemotherapy, Adjuvant Case-Control Studies Propensity Score Databases, Factual Treatment Failure Sex Distribution Combined Modality Therapy Analysis of Variance Logistic Models Denmark Randomized Controlled Trials as Topic Prostate-Specific Antigen Antiretroviral Therapy, Highly Active Socioeconomic Factors CD4 Lymphocyte Count Prostatectomy China Coffee African Continental Ancestry Group Life Tables Hypertension Survival Genotype Life Style Netherlands Finland Prevalence

No FAQ available that match "model of proportional hazards"